STRASBOURG, France, December 19, 2014.
Syndivia and SATT Conectus have signed a licence agreement for APN technology allowing preparation of bioconjugates with increased stability in circulation.
STRASBOURG, France, December 19, 2014.
Syndivia and SATT Conectus have signed a licence agreement for APN technology allowing preparation of bioconjugates with increased stability in circulation.